Skip to main content

Small Molecules in Oncology

  • Book
  • © 2018

Overview

  • Discusses the most recent developments in targeted therapy in oncology using small molecules
  • Describes chemical structure, mechanism of action, drug targets, and drug interactions
  • Examines preclinical studies, clinical trials, and treatment applications

Part of the book series: Recent Results in Cancer Research (RECENTCANCER, volume 211)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (18 chapters)

Keywords

About this book

This book, written by respected experts, discusses in detail the latest developments in targeted oncology therapy using small molecules. It covers a wide range of small molecules, including tyrosine kinase inhibitors, mTOR, MEK, PARP, and multikinase inhibitors, as well as cell cycle and NTRK interacting agents. For each molecule, aspects such as the chemical structure, mechanism of action, drug targets, drug interactions, preclinical studies, clinical trials, treatment applications, and toxicity are discussed. 

Extensive research into the molecular mechanisms of cancer has heralded a new age of targeted therapy. The field of personalized cancer therapy is now growing rapidly, and the advances being made will mean significant changes in the treatment algorithms for cancer patients. Numerous novel targets that are crucial for the survival of cancer cells can be attacked by small molecules such as protein tyrosine kinase inhibitors. This book is the third edition of Small Molecules in Oncology, but has now been divided into two volumes, with the other volume focusing specifically on small molecules in hematology. 



Editors and Affiliations

  • MOLIT Institute, Cancer Center Heilbronn-Franken, SLK-Clinics, Heilbronn, Germany

    Uwe M. Martens

About the editor

Uwe Martens, Prof. Dr. med., is chair of the Cancer Center Heilbronn-Franken and head of the Department of Hematology and Oncology at the SLK Clinic Heilbronn, which is an academic teaching hospital of the University of Heidelberg. He graduated in Medicine from the University of Freiburg and continued his medical and scientific training at the Medical University Center in Freiburg and at the BC Cancer Research Center in Vancouver. His scientific focus is the development of personalized cancer therapy and immunotherapy. He is a co-founder of the MOLIT Institute for Personalized Medicine at the science and technology park in Heilbronn, which aims to rapidly translate precision medicine into standard care.

Bibliographic Information

  • Book Title: Small Molecules in Oncology

  • Editors: Uwe M. Martens

  • Series Title: Recent Results in Cancer Research

  • DOI: https://doi.org/10.1007/978-3-319-91442-8

  • Publisher: Springer Cham

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer International Publishing AG, part of Springer Nature 2018

  • Hardcover ISBN: 978-3-319-91441-1Published: 13 August 2018

  • Softcover ISBN: 978-3-030-08257-4Published: 05 January 2019

  • eBook ISBN: 978-3-319-91442-8Published: 01 August 2018

  • Series ISSN: 0080-0015

  • Series E-ISSN: 2197-6767

  • Edition Number: 3

  • Number of Pages: VIII, 276

  • Number of Illustrations: 15 b/w illustrations, 19 illustrations in colour

  • Additional Information: Originally published in one volume in previous edition

  • Topics: Oncology, Cancer Research

Publish with us